Generated Narrative: Evidence

url: https://fevir.net/resources/Evidence/47695

identifier: FEvIR Object Identifier/47695

version: 1.0.0-ballot

name: ComparativeEvidence_Mean_difference_in_HbA1c_between_Surgery_and_Medical_Lifestyle_groups_in_Mingrone_2015_DIBASY_trial

title: ComparativeEvidence: Mean difference in HbA1c between Surgery and Medical/Lifestyle groups in Mingrone 2015 (DIBASY) trial

status: active

date: 2022-05-29 11:07:10+0000

publisher: HL7 International / Clinical Decision Support

contact: HL7 International / Clinical Decision Support: http://www.hl7.org/Special/committees/dss

author: Brian S. Alper:

UseContexts

copyright: https://creativecommons.org/licenses/by-nc-sa/4.0/

relatedArtifact

type: derived-from

label: data source

display: Figure 2C

citation: Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations [Journal Article]. Contributors: Francesco Rubino, David M Nathan, Robert H Eckel, Philip R Schauer, K George M M Alberti, Paul Z Zimmet, Stefano Del Prato, Linong Ji, Shaukat M Sadikot, William H Herman, Stephanie A Amiel, Lee M Kaplan, Gaspar Taroncher-Oldenburg, David E Cummings, Delegates of the 2nd Diabetes Surgery Summit. In: Diabetes care, PMID 27222544. Published June 2016. Available at: https://pubmed.ncbi.nlm.nih.gov/27222544/.

document

relatedArtifact

type: cite-as

citation: ComparativeEvidence: Mean difference in HbA1c between Surgery and Medical/Lifestyle groups in Mingrone 2015 (DIBASY) trial [Evidence]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 47695. Revised 2022-05-29. Available at: https://fevir.net/resources/Evidence/47695. Computable resource at: https://fevir.net/resources/Evidence/47695.

description: Mean HbA1c at 60 months in Mingrone 2015 was 6.55% in Surgery group (n = 38) and 6.9% in Medical/Lifestyle group (n = 15), mean difference -0.35% (95% CI -0.69% to -0.01%)

variableDefinition

VariableDefinitionVariableRoleCode: population

description: 53 patients aged 30-60 years with BMI of 35 or more and a history of T2DM lasting at least 5 years

note: population

variableRole: Use extension:variableRoleCode instead. (EvidenceVariableRole#population "population")

observed: Group/46117: StudyGroup: DIBASY Trial Enrollment Group "StudyGroup_DIBASY_Trial_Enrollment_Group"

variableDefinition

VariableDefinitionVariableRoleCode: exposure

VariableDefinitionComparatorCategory: medical treatment

description: Roux-en-Y gastric bypass or Biliopancreatic Diversion vs. medical treatment

note: exposure

variableRole: Use extension:variableRoleCode instead. (EvidenceVariableRole#exposure "exposure")

observed: EvidenceVariable/172479: GroupAssignment: Roux-en-Y gastric bypass or Biliopancreatic Diversion vs. medical treatment "GroupAssignment_Roux_en_Y_gastric_bypass_or_Biliopancreatic_Diversion_vs_medical_treatment"

variableDefinition

VariableDefinitionVariableRoleCode: outcome

description: HbA1c at 60 months

note: outcome

variableRole: Use extension:variableRoleCode instead. (EvidenceVariableRole#measuredVariable "measured variable")

observed: EvidenceVariable/173247: OutcomeVariable: HbA1c at 60 months "OutcomeVariable_HbA1c_at_60_months"

synthesisType: not applicable (StatisticSynthesisType#NotApplicable)

studyDesign: randomized assignment (Scientific Evidence Code System (SEVCO) -- EXAMPLE VERSION for EBMonFHIR Implementation Guide#SEVCO:01003)

statistic

description: mean difference -0.35% (95% CI -0.69% to -0.01%)

note: Mean HbA1c at 60 months in Mingrone 2015 was 6.55% in Surgery group (n = 38) and 6.9% in Medical/Lifestyle group (n = 15)

statisticType: Mean Difference (StatisticStatisticType#0000457)

quantity: -0.35 % (Details: UCUM code % = '%')

SampleSizes

-	NumberOfParticipants	KnownDataCount
*	53	53

AttributeEstimates

-	Description	Type	Level	Range
*	95% CI -0.69% to -0.01%	Confidence interval (StatisticAttribute Estimate Type#C53324)	0.95	-0.69--0.01 %